... through idea and creative work as part of a multi-channel launch.
Orexo develops and commercialises drugs and digital therapies that fill an important need in the growing field of mental illness and addiction diseases.
In autumn 2021, Orexo launched amorphOX™, a new and versatile platform for drug formulation. This is based on an innovative powder-based technology, which is fast-soluble, stable and works with various active substances, dosage forms and routes of administration. The combination of rapid uptake, high stability and long shelf life is unique among drugs based on an amorphous structure. Today, Orexo uses the technology in three development projects and amorphOX™ will also be the backbone of other future drugs.
Together with Orexo, Solberg was responsible for storyboard, copywriting and illustrations for film in connection with the multi-channel launch of amorphOX™.
Contact us to know more!
